Evidence map›Paper›PMID 15373935›Full record

ArticleBritish journal of clinical pharmacology2004

European surveillance of antimicrobial consumption (ESAC): data collection performance and methodological approach.

R H Vander Stichele, M M Elseviers, M Ferech, S Blot, H Goossens, ESAC Project Group

Abstract readMulticenter Study
In one paragraph

Article in British journal of clinical pharmacology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Antibiotic Utilization in Pediatric Hospitalized Patients - A Single Center Study.Open access Macedonian journal of medical sciences · 2017
    Article
  12. Article
  13. Article
  14. Role of Pharmacovigilance in India: An overview.Online journal of public health informatics · 2015
    Article
  15. Article
  16. Assessing the impact of national antibiotic campaigns in Europe.The European journal of health economics : HEPAC : health economics in prevention and care · 2013
    Article
  17. Antimicrobial agent exposure and the emergence and spread of resistant microorganisms: issues associated with study design.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2013
    Review
  18. Article
  19. Review
  20. Surveillance system for hepatitis C infection: A practical approach.International journal of preventive medicine · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

R H Vander SticheleESAC Management Team, Department of Microbiology, University of Antwerp, Antwerp, Belgium. robert.vanderstichele@ugent.be
M M Elseviers
M Ferech
S Blot
H Goossens
ESAC Project Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEurope is a continent with strong public healthcare systems, but diverging antibiotic policies and resistance patterns.

aimsTo describe the performance and methodological approach in a retrospective data collection effort (1997-2001), through an international network of surveillance systems, aiming to collect publicly available, comparable and reliable data on antibiotic use in Europe.

methodsA central multidisciplinary management team co-ordinated a network of national representatives, liasing with national data providers and bodies responsible for antibiotic policy. The data collected were screened for bias, using a checklist. We focused on detection bias in sample and census data; errors in assigning medicinal product packages to the Anatomical Therapeutic Chemical Classification (ATC); errors in calculations of defined daily doses (DDD) per package; bias by over-the-counter sales and parallel trade; and bias in ambulatory care (AC)/hospital care (HC) mix. Datasets were corrected after national feedback, and classified as valid; valid but with minor bias; not valid.

resultsOf the 31 participating countries, 21 countries delivered AC data suitable for cross-national comparison (14 for all 5 years). Of these, 17 countries provided data on a quarterly basis for at least 1 year. For HC, 14 countries were able to deliver valid data (nine for all 5 years). A valid estimate of the total exposure of national populations to human antibiotic consumption could be made in 17 countries.

conclusionIn cross-national comparisons of antibiotic consumption in Europe, methodological rigour in correcting for various sources of bias and checking the validity of ATC/DDD assignment is needed.

Indexed as

Anti-Bacterial AgentsData CollectionEuropeHospitalizationHumansAnti-Bacterial Agents

Identifiers

PMID15373935
PMCPMC1884596

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.